These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6348577)

  • 21. Hydrocephalus and vasospasm after subarachnoid hemorrhage from ruptured intracranial aneurysms.
    Black PM
    Neurosurgery; 1986 Jan; 18(1):12-6. PubMed ID: 3945373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention and treatment of vasospasm.
    Levati A; Solaini C; Boselli L
    J Neurosurg Sci; 1998 Mar; 42(1 Suppl 1):27-31. PubMed ID: 9800599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of computed tomography in the management of vasospasm after subarachnoid hemorrhage.
    Pasqualin A; Rosta L; Da Pian R; Cavazzani P; Scienza R
    Neurosurgery; 1984 Sep; 15(3):344-53. PubMed ID: 6483149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of timing of clot removal on chronic vasospasm in a primate model.
    Handa Y; Weir BK; Nosko M; Mosewich R; Tsuji T; Grace M
    J Neurosurg; 1987 Oct; 67(4):558-64. PubMed ID: 3655894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective study on the prevention of cerebral vasospasm by intrathecal fibrinolytic therapy with tissue-type plasminogen activator.
    Mizoi K; Yoshimoto T; Takahashi A; Fujiwara S; Koshu K; Sugawara T
    J Neurosurg; 1993 Mar; 78(3):430-7. PubMed ID: 8433145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of subarachnoid hemorrhage.
    Rosenwasser RH; Buchheit WA; Truex RC
    Pa Med; 1984 Dec; 87(12):72, 74, 76. PubMed ID: 6542649
    [No Abstract]   [Full Text] [Related]  

  • 27. Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage.
    Findlay JM; Weir BK; Kassell NF; Disney LB; Grace MG
    J Neurosurg; 1991 Aug; 75(2):181-8. PubMed ID: 1906533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depression of circulating blood volume in patients after subarachnoid hemorrhage: implications for the management of symptomatic vasospasm.
    Solomon RA; Post KD; McMurtry JG
    Neurosurgery; 1984 Sep; 15(3):354-61. PubMed ID: 6483150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension.
    Iberti TJ
    Neurosurgery; 1983 Jun; 12(6):705-6. PubMed ID: 6877556
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical effect of nitroglycerin (GTN) on prevention of cerebral vasospasm].
    Sasanuma J; Goto T; Ogayama H; Sasaki J; Watanabe K
    No Shinkei Geka; 1991 Mar; 19(3):227-32. PubMed ID: 1903850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiographic study of cerebral vasospasm following rupture of intracranial aneurysms: Part I. Time of the appearance.
    Kwak R; Niizuma H; Ohi T; Suzuki J
    Surg Neurol; 1979 Apr; 11(4):257-62. PubMed ID: 441910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Caveats for triple-H therapy in the management of vasospasm after aneurysmal subarachnoid hemorrhage.
    Hunt MA; Bhardwaj A
    Crit Care Med; 2007 Aug; 35(8):1985-6. PubMed ID: 17667248
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical response to hypertensive hypervolemic therapy and outcome after subarachnoid hemorrhage.
    Frontera JA; Fernandez A; Schmidt JM; Claassen J; Wartenberg KE; Badjatia N; Connolly ES; Mayer SA
    Neurosurgery; 2010 Jan; 66(1):35-41; discussion 41. PubMed ID: 20023535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm.
    Findlay JM; Kassell NF; Weir BK; Haley EC; Kongable G; Germanson T; Truskowski L; Alves WM; Holness RO; Knuckey NW
    Neurosurgery; 1995 Jul; 37(1):168-76; discussion 177-8. PubMed ID: 8587685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral vasospasm patterns following aneurysmal subarachnoid hemorrhage: an angiographic study comparing coils with clips.
    Jones J; Sayre J; Chang R; Tian J; Szeder V; Gonzalez N; Jahan R; Vinuela F; Duckwiler G; Tateshima S
    J Neurointerv Surg; 2015 Nov; 7(11):803-7. PubMed ID: 25230840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental subarachnoid hemorrhage in the cynomolgus monkey: evaluation of treatment with hypertension, volume expansion, and ventilation.
    Ritchie WL; Weir B; Overton TR
    Neurosurgery; 1980 Jan; 6(1):57-62. PubMed ID: 6766538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution of angiographic vasospasm after subarachnoid hemorrhage: implications for diagnosis by transcranial Doppler ultrasonography.
    Newell DW; Grady MS; Eskridge JM; Winn HR
    Neurosurgery; 1990 Oct; 27(4):574-7. PubMed ID: 2234360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of clot removal at 24 hours on chronic vasospasm after SAH in the primate model.
    Nosko M; Weir BK; Lunt A; Grace M; Allen P; Mielke B
    J Neurosurg; 1987 Mar; 66(3):416-22. PubMed ID: 3819837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of lipid peroxidation in the genesis of vasospasm secondary to subarachnoid hemorrhage.
    Caner H; Oruçkaptan H; Bolay H; Kilinç K; Senaati S; Benli K; Ayhan A
    Kobe J Med Sci; 1991 Feb; 37(1):13-20. PubMed ID: 1921259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial.
    Shibuya M; Suzuki Y; Sugita K; Saito I; Sasaki T; Takakura K; Nagata I; Kikuchi H; Takemae T; Hidaka H
    J Neurosurg; 1992 Apr; 76(4):571-7. PubMed ID: 1545249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.